Author: Ayer Jean Young Helen S
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.14, Iss.6, 2013-04, pp. : 767-774
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral pimecrolimus beneficial in psoriasis and atopic dermatitis
Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. :
Mast Cells as Targets of Pimecrolimus
Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. :
Boxed warning recommended for tacrolimus/pimecrolimus
Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. :
Pimecrolimus: Tinea incognito: case report
Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. :